当前位置: 首页 > 医疗版 > 疾病专题 > 中医疾病
编号:13058661
抗HBsAg抗体在乙型肝炎相关疾病中的应用进展(3)
http://www.100md.com 2017年4月9日 《医学信息》 2017年第14期
     [6]Zhang T Y,Yuan Q,Zhao J H,et al.Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen[J].Gut,2015,65(4):658-671.

    [7]Kucinskaite-Kodze I,Pleckaityte M,Bremer C M,et al.New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen[J].Virus Research,2015,211:209-221.

    [8]Tan W,Meng Y,Li H,et al.A bispecific antibody against two different epitopes on hepatitis B surface antigen has potent hepatitis B virus neutralizing activity[J].Mabs,2012,5(6):946-955.

    [9]Saitta C,Tripodi G,Barbera A,et al.Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma[J].Liver International,2015,35(10):2311-2317.

    [10]Yan B,Ouyang Q,Zhao Z,et al.Potent killing of HBV-related hepatocellular carcinoma by a chimeric protein of anti-HBsAg single-chain antibody and truncated Bid[J].Biomaterials, 2013,34(20):4880-4889.

    [11]Wen WH,Liu JY,Qin WJ,et al.Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery[J].Hepatology,2007,46(1):84-94.

    [12]Carlo F.HBV and the immune response[J].Liver International,2015,35(Suppl.1):121-128.

    [13]Op den Brouw ML,Binda RS,van Roosmalen MH,et al. Hepatitis B virus surface antigen impairs myeloid dendritic cell function:a possible immuneescape mechanism of hepatitis B virus[J].Immunology,2009,126(2):20-9.

    [14]Jiang M,Broering R,Trippler M,et al.Toll-like receptor-mediated immune responses are attenuated in the presence of high levels ofhepatitis B virus surface antigen[J].Journal of viral hepatitis,2014,21(12):860-872.

    [15]Tharinger H,Rebbapragada I,Samuel D,et al.Antibody-dependent and antibody-independent uptake of HBsAg across human leucocyte subsets is similar between individuals with chronic hepatitis B virus infection and healthy donors[J].Journal of viral hepatitis,2017:1-8.

    [16]Zhu D,Liu L,Yang D,et al.Clearing Persistent Extracellular Antigen of Hepatitis B Virus:An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination[J].Journal of Immunology,2016,196(7).

    編辑/成森, 百拇医药(杨玥 刘煜)
上一页1 2 3


    参见:首页 > 医疗版 > 疾病专题 > 中医疾病